A Randomized Phase II Study of Gemcitabine and Carboplatin with or without Cediranib as First-Line Therapy in Advanced Non–Small-Cell Lung Cancer: North Central Cancer Treatment Group Study N0528
Dy, Grace K., Mandrekar, Sumithra J., Nelson, Garth D., Meyers, Jeffrey P., Adjei, Araba A., Ross, Helen J., Ansari, Rafat H., Lyss, Alan P., Stella, Philip J., Schild, Steven E., Molina, Julian R., AVolume:
8
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/JTO.0b013e318274a85d
Date:
January, 2013
File:
PDF, 852 KB
english, 2013